CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade PharmaCyte Biotech, Inc. - PMCB CFD

1.95
0%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.05
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.02629 %
Charges from full value of position ($-5.00)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.02629%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.004068 %
Charges from full value of position ($0.77)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004068%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 1.95
Open 1.94
1-Year Change -30.71%
Day's Range 1.94 - 1.99
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jul 19, 2024 1.95 0.01 0.52% 1.94 1.99 1.94
Jul 18, 2024 1.95 -0.05 -2.50% 2.00 2.00 1.95
Jul 17, 2024 2.01 -0.02 -0.99% 2.03 2.05 2.00
Jul 16, 2024 2.00 0.00 0.00% 2.00 2.03 2.00
Jul 15, 2024 1.97 -0.02 -1.01% 1.99 2.01 1.96
Jul 12, 2024 1.99 -0.07 -3.40% 2.06 2.07 1.97
Jul 11, 2024 2.03 0.08 4.10% 1.95 2.05 1.93
Jul 10, 2024 2.04 0.03 1.49% 2.01 2.05 2.01
Jul 9, 2024 2.00 -0.08 -3.85% 2.08 2.08 2.00
Jul 8, 2024 2.10 0.01 0.48% 2.09 2.10 2.09
Jul 5, 2024 2.03 0.05 2.53% 1.98 2.03 1.98
Jul 3, 2024 1.99 -0.01 -0.50% 2.00 2.03 1.98
Jul 2, 2024 2.04 0.00 0.00% 2.04 2.10 2.04
Jul 1, 2024 1.94 0.00 0.00% 1.94 1.95 1.94
Jun 28, 2024 1.96 -0.07 -3.45% 2.03 2.04 1.96
Jun 27, 2024 2.04 0.02 0.99% 2.02 2.04 2.00
Jun 26, 2024 2.01 -0.05 -2.43% 2.06 2.06 2.01
Jun 25, 2024 2.02 0.04 2.02% 1.98 2.08 1.98
Jun 24, 2024 1.99 -0.01 -0.50% 2.00 2.00 1.95
Jun 21, 2024 1.97 -0.01 -0.51% 1.98 2.03 1.95

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

PharmaCyte Biotech, Inc. Company profile

About Pharmacyte Biotech Inc

PharmaCyte Biotech, Inc. is a clinical-stage biotechnology company. The Company is focused on developing cellular therapies for cancer and diabetes based upon a cellulose-based live cell encapsulation technology known as Cell-in-a-Box. Cell-in-a-Box technology is used as a platform upon which therapies for several types of cancer, including locally advanced, inoperable, non-metastatic pancreatic cancer (LAPC). The Company's lead product candidate, CypCaps is in Phase II of the clinical trials in LAPC. It also focused on developing a therapy for Type 1 diabetes and insulin-dependent Type 2 diabetes. Its product candidate for the treatment of diabetes consists of encapsulated genetically modified insulin-producing cells. The Company is also focused on the benefits of the Cell-in-a-Box technology to develop therapies for cancer that involve prodrugs based upon certain constituents of the Cannabis plant, such as cannabinoids.

Financial summary

BRIEF: For the nine months ended 31 January 2022, Pharmacyte Biotech Inc revenues was not reported. Net loss increased 9% to $2.8M. Higher net loss reflects General and administrative increase from $291K to $836K (expense), Legal and professional increase of 85% to $601K (expense), Director fees increase of 1% to $209K (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$1.88 to -$0.74.

Equity composition

Common Stock $0.0001 Par, 03/11, 500M auth., 353,387,581 issd. Insiders own 9.09%. 12/03, 3 for 1 forward stock split. 03/09, Name changed from eFoodSafety.com Inc. Preferred Stock $.0001 Par, 10M auth., 5K issd.

Industry: Pharmaceuticals (NEC)

3960 Howard Hughes Parkway, Suite 500
LAS VEGAS
NEVADA 89169
US

People also watch

BTC/USD

66,584.55 Price
-0.640% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

XRP/USD

0.60 Price
+3.480% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Gold

2,401.36 Price
-1.830% 1D Chg, %
Long position overnight fee -0.0198%
Short position overnight fee 0.0116%
Overnight fee time 21:00 (UTC)
Spread 1.20

ETH/USD

3,499.15 Price
-0.330% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

Still looking for a broker you can trust?

Join the 630,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading